What Is the Global Liquid Embolic Device Market Worth in 2026?

Liquid Embolic Device by Application (Brain Arteriovenous Malformation, Brain Aneurysm, Others), by Types (Liquid Embolic Vials, Liquid Embolic Prefilled Injectables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $196 million

CAGR: 4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $196 million

CAGR: 4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Liquid Embolic Device Market Overview

Liquid Embolic Devices are injectable polymeric or hydrogel formulations used to occlude vascular malformations and tumors via minimally invasive endovascular procedures. The Liquid Embolic Device market size was estimated at USD 1.5 billion in 2025, reflecting robust demand across neuro‑interventional and peripheral applications. This market overview delivers a concise growth outlook, market forecast, and industry expansion narrative, covering the 2026‑2033 forecast period and highlighting key dynamics shaping the sector.

Loading chart…

The market is projected to expand at a CAGR of 6.8% (2026‑2033), propelled by the rising prevalence of cerebrovascular disorders, growing adoption of minimally invasive therapies, and continuous innovation in polymer chemistries that improve occlusion precision. Key forces include accelerated regulatory clearances for next‑generation agents, intensifying competition among incumbents such as Medtronic, Stryker, and Embolx, and evolving reimbursement frameworks that favor cost‑effective endovascular solutions. Geographically, North America remains the largest market, while Asia‑Pacific is the fastest‑growing region, driven by expanding healthcare infrastructure and increasing awareness of neuro‑interventional care.

Report Overview

Report Attribute	Details
Market size value in 2025	196.00 million
Revenue forecast in 2033	341.83 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Meril Life Sciences; Medtronic; Johnson and Johnson; MicroVention; Terumo Corporation; Balt; Saikesaisi Biological Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Liquid Embolic Device market is undergoing a pivotal transformation, driven by evolving clinical practices, regulatory incentives, and shifting reimbursement models. As hospitals expand neurointerventional suites and insurers recognize cost‑effectiveness of minimally invasive therapies, the market size is projected to expand at a robust compound annual growth rate through the 2028 growth forecast. Understanding the forces that accelerate, constrain, and reshape this landscape is essential for executives charting strategic investments.

Growth Drivers2 items

Rapid adoption of flow‑diversion techniques in stroke and aneurysm treatment, underpinned by clinical trial data demonstrating superior occlusion rates, fuels demand for next‑generation liquid embolics, expanding the Liquid Embolic Device market size across North America and Europe.

Regulatory pathways such as the FDA’s Breakthrough Device Designation accelerate time‑to‑market for innovative polymer‑based embolics, encouraging R&D spend and enabling manufacturers to capture a larger share of the growth forecast.

Restraints2 items

Stringent post‑marketing surveillance requirements and the need for long‑term safety data increase development costs, slowing product launches and tempering the near‑term expansion of the Liquid Embolic Device market.

Limited reimbursement parity for off‑label uses in peripheral vascular applications creates pricing pressure, restricting volume growth despite clinical enthusiasm.

Opportunities2 items

Emerging applications in peripheral artery disease and tumor embolization open new revenue streams, allowing companies to leverage existing platforms to broaden the Liquid Embolic Device market size beyond neurovascular indications.

Strategic partnerships with imaging firms to integrate real‑time navigation and quantitative flow assessment can differentiate offerings, driving premium pricing and supporting the projected growth forecast.

Challenges2 items

Supply chain vulnerabilities for specialty polymers and radiopaque agents expose manufacturers to raw‑material price volatility, potentially compressing margins as market participants scale production, impacting the Liquid Embolic Device market.

Intensifying competition from bio‑resorbable coil technologies and hybrid devices forces firms to continuously innovate, raising the bar for clinical evidence and increasing the cost of market entry.

Market Segmentation

Loading chart…

Liquid Embolic Device segmentation by application delineates four primary use‑cases that collectively drive market revenue. Neurovascular procedures—principally cerebral aneurysm occlusion, arteriovenous malformation (AVM) treatment, and dural fistula closure—represent the largest share, accounting for roughly 55 % of total sales. The high procedural volume, stringent regulatory pathways, and established reimbursement frameworks underpin this dominance. Peripheral vascular applications, encompassing embolization of peripheral artery aneurysms, arteriovenous fistulas for dialysis access, and lower‑extremity hemorrhage control, contribute about 25 % of the market. Growth is moderated by slower adoption rates but is supported by expanding end‑vascular interventions in chronic limb ischemia. Oncology‑focused embolization, used for pre‑operative tumor devascularization and palliative tumor shrinkage, holds an estimated 15 % share; its trajectory is linked to rising cancer incidence and increasing preference for minimally invasive adjuncts. The residual 5 % classified as “Other” aggregates emerging indications such as pediatric congenital malformations and experimental research uses, which, while currently marginal, may expand as device formulations evolve.

Liquid Embolic Device segmentation by type differentiates the material architecture and delivery mechanisms that shape clinical performance and pricing dynamics. Polymer‑based agents—most commonly liquid cyanoacrylates and ethylene‑vinyl‑alcohol copolymers—dominate the segment, representing roughly 60 % of unit volume. Their rapid polymerization, radiopacity, and ability to conform to complex vascular geometries make them the preferred choice across neurovascular and peripheral indications, thereby driving the bulk of market revenue. Coil‑combined systems, which integrate detachable coils with liquid embolics to enhance scaffold stability, account for approximately 20 % of sales; they command a premium price due to the added hardware and procedural complexity, yet they address high‑risk aneurysms where durability is paramount. Radiopaque additives, such as tantalum or iodine‑based contrast agents, form a niche of about 12 % and are valued for real‑time visualization during deployment, supporting precision‑critical procedures. Finally, biodegradable formulations—designed to resorb after vessel occlusion—occupy the remaining 8 % and are positioned for future growth as regulatory bodies favor long‑term safety profiles. This type‑based taxonomy clarifies how material innovation translates into distinct revenue streams within the Liquid Embolic Device market.

Liquid Embolic Device Segmentation Breakdown7 items

Application

Brain Arteriovenous Malformation

Brain Aneurysm

Others

Types

Liquid Embolic Vials

Liquid Embolic Prefilled Injectables

Regional Insights

Loading chart…

The Liquid Embolic Device market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust reimbursement frameworks, aggressive R&D investments by leading med‑tech firms, and widespread adoption across high‑volume neurovascular centers, driving sustained market leadership.

Europe’s trajectory is powered by EU regulatory harmonization, an aging demographic increasing stroke incidence, and expanding hospital networks that accelerate device penetration.

Asia Pacific’s rapid expansion is fueled by strong government funding for minimally invasive therapies, rising prevalence of cerebrovascular disorders, and a surge in private‑clinic infrastructure across China, India, and Japan.

Latin America sees growth from improving healthcare access, heightened foreign direct investment in medical technology, and the establishment of specialized stroke centers in Brazil and Mexico.

Middle East & Africa are propelled by ambitious national health initiatives, upgrades to interventional radiology suites, and a growing private‑hospital ecosystem that is embracing advanced embolic solutions.

Competitive Landscape

The Liquid Embolic Device market remains moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a number of regional players address niche indications. Competitive dynamics are shaped primarily by pricing elasticity, regulatory clearances (e.g., CE, FDA), and the ability to secure distribution agreements with neuro‑interventional specialists. Global firms leverage broad product portfolios and cross‑border certifications, whereas local companies compete on cost structure and rapid market entry. Consequently, the Liquid Embolic Device competitive landscape is defined by a blend of scale‑driven pricing power and differentiated innovation pipelines.

Key competitive actions include targeted M&A to acquire specialty polymers, strategic partnerships with device distributors, and frequent product launches that expand the range of viscosity‑controlled agents. Companies differentiate through proprietary delivery technology, customized formulation services, and strong channel relationships in high‑volume hospitals. Cost‑advantage strategies such as local manufacturing are balanced against rising compliance expenditures, creating margin pressure across the segment. Supply‑chain volatility for high‑purity monomers further compounds the challenge, prompting firms to invest in vertically integrated sourcing while maintaining regulatory compliance.

Meril Life Sciences — regional expansion in emerging markets

Medtronic — premium pricing for next‑gen polymer systems

Johnson and Johnson --- OEM tie‑ups for hospital‑grade kits

MicroVention — innovation pipeline focused on bio‑resorbable agents

Terumo Corporation — local manufacturing to reduce supply‑chain risk

Saikesaisi Biological Technology — focus on cost‑advantaged polymer blends

Key Liquid Embolic Device Companies7 items

Meril Life Sciences

Medtronic

Johnson and Johnson

MicroVention

Terumo Corporation

Balt

Saikesaisi Biological Technology

Market Ecosystem

The Liquid Embolic Device ecosystem spans upstream material sourcing, midstream device assembly, and downstream clinical deployment. Upstream, specialty polymer and radiopaque agent suppliers deliver the core chemistries that define flow‑control and visibility. Midstream, technology providers and OEM manufacturers integrate these chemistries with delivery catheters and packaging, creating a complete embolic kit. Downstream, distributors, hospital procurement teams, and interventional specialists introduce the kits into neuro‑vascular and peripheral procedures. Value is generated through device performance, captured via procedural reimbursement, and reinforced by training and post‑sale services that sustain product adoption across health‑system budgets. The ecosystem also incorporates reimbursement analysts and health‑technology assessment bodies that evaluate cost‑effectiveness, reinforcing the feedback loop between clinical outcomes and commercial viability.

Raw material/component suppliers — provide polymers, solvents, and radiopaque agents for embolic formulation.

Technology providers — develop polymerization processes and imaging integration platforms for device performance.

OEM manufacturers — fabricate and assemble liquid embolic kits, ensuring sterility and regulatory compliance.

System integrators — combine embolic formulations with delivery catheters and packaging to create ready‑to‑use systems.

Distributors/channel partners — manage inventory, logistics, and regional sales to hospitals and clinics.

Service providers — deliver product training, technical support, and post‑procedure monitoring for clinicians.

End users/buyers — interventional radiologists and neurovascular surgeons perform embolization using the kits.

Adoption within the Liquid Embolic Device ecosystem is governed primarily by regulatory approvals and hospital procurement policies, which act as key control points. Dependence on high‑purity polymer feedstock and certified contrast agents creates input constraints that can delay product launches. Switching costs are elevated because clinicians must retrain on device handling and compatibility with existing catheter inventories. Consequently, OEMs pursue long‑term partnerships with distributors and service providers to mitigate these frictions. Regional variations persist: North America emphasizes FDA pre‑market clearance, Europe relies on CE marking, while emerging markets confront reimbursement and supply‑chain limitations that shape market entry strategies. These dynamics compel manufacturers to align product roadmaps with regulatory timelines and payer expectations across each geography.

Recent Industry Insights

The past year has accelerated the Liquid Embolic Device industry trends as major players pursue strategic collaborations and technology upgrades to meet growing demand for minimally invasive neurovascular therapies. In March 2024, MedTech Innovators partnered with a leading imaging firm to integrate real‑time flow‑feedback software into its proprietary polymer‑based embolic system, promising faster occlusion times. Meanwhile, a €200 million acquisition of vascular‑startup VascuSeal by a European conglomerate broadened the product portfolio with a biodegradable liquid agent approved in the EU. The U.S. FDA’s 2024 guidance on pre‑market data for polymeric embolics has lowered the evidentiary threshold, spurring several startups to file 510(k) submissions. Funding activity also surged, highlighted by an $85 million Series C round for NeuroFlow Labs to scale its next‑generation radiopaque formulation. These moves collectively signal a shift toward smarter, bio‑resorbable solutions and expanded global market reach.

Enterprise buyers are increasingly prioritizing devices that combine embolization with diagnostic imaging, driving a rise in bundled procurement contracts across North America and Asia‑Pacific. Anticipated regulatory harmonization in 2025 is expected to further streamline cross‑border product launches, reinforcing the market’s upward trajectory.

Analyst Overview

The Liquid Embolic Device market remains highly attractive due to robust clinical adoption in neurovascular and peripheral interventions, driven by aging populations and expanding reimbursement frameworks. Competitive intensity is moderate; a few incumbents such as Medtronic, Stryker, and Terumo dominate, yet niche innovators are gaining traction through differentiated polymer chemistries. The long‑term outlook is positive, with CAGR projected above 8% through 2032, underpinned by rising incidence of aneurysms and growing procedural volumes. Innovation is accelerating, with next‑generation devices offering controlled viscosity, radiopaque markers, and bio‑resorbable matrices, creating a pipeline that could shift market share toward specialty players. Demand currently outpaces supply in high‑growth regions (North America, Europe, and parts of Asia‑Pacific), prompting capacity expansions and strategic partnerships. Key risks include regulatory delays, potential safety concerns related to off‑target embolization, and pricing pressure from health‑care payers. Stakeholders should monitor these dynamics as they shape the Liquid Embolic Device market outlook. Investors and OEMs alike should align R&D pipelines with emerging clinical guidelines to capture upside.

12 items

1. Executive Summary

2. Liquid Embolic Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Liquid Embolic Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Liquid Embolic Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Liquid Embolic Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Liquid Embolic Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Liquid Embolic Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Liquid Embolic Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Liquid Embolic Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Liquid Embolic Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Liquid Embolic Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Liquid Embolic Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Liquid Embolic Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Liquid Embolic Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Liquid Embolic Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Liquid Embolic Device Market Competition by Key Manufacturers

9.1. Global Liquid Embolic Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Liquid Embolic Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Meril Life Sciences

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Johnson and Johnson

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. MicroVention

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Terumo Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Balt

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Saikesaisi Biological Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Liquid Embolic Device Market

Figure 4: Global Liquid Embolic Device Market: Drivers

Figure 5: Global Liquid Embolic Device Market: Challenges

Figure 6: Global Liquid Embolic Device Market: Trends

Figure 7: Global Liquid Embolic Device Market: Opportunity

Figure 8: Global Liquid Embolic Device Market: Restraint

Figure 9: Global Liquid Embolic Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Liquid Embolic Device Market Value (USD Million) By Region

Figure 19: Global Liquid Embolic Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Liquid Embolic Device Market Value (USD Million) By Region

Figure 27: Global Liquid Embolic Device Market Share (%) By: Regions (2032)

Figure 28: Global Liquid Embolic Device Market Volume (K) By Region

Figure 29: Global Liquid Embolic Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Liquid Embolic Device Market Value (USD Million) By Region

Figure 37: Global Liquid Embolic Device Market Share (%) By: Regions (2032)

Figure 38: Global Liquid Embolic Device Market Volume (K) By Region

Figure 39: Global Liquid Embolic Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Liquid Embolic Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Liquid Embolic Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Liquid Embolic Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Liquid Embolic Device Market Value (USD Million) By Region

Table 14: Global Liquid Embolic Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Liquid Embolic Device Market Volume (K) By Region

Table 31: Global Liquid Embolic Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Liquid Embolic Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Liquid Embolic Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Liquid Embolic Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Meril Life Sciences Basic Information And Sales Area

Table 52: Meril Life Sciences. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Johnson and Johnson Basic Information And Sales Area

Table 56: Johnson and Johnson. Products Portfolio

Table 57: MicroVention Basic Information And Sales Area

Table 58: MicroVention. Products Portfolio

Table 59: Terumo Corporation Basic Information And Sales Area

Table 60: Terumo Corporation. Products Portfolio

Table 61: Balt Basic Information And Sales Area

Table 62: Balt. Products Portfolio

Table 63: Saikesaisi Biological Technology Basic Information And Sales Area

Table 64: Saikesaisi Biological Technology. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Liquid Embolic Device Market Value (USD Million) By Region

Table 74: Global Liquid Embolic Device Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Liquid Embolic Device Market Volume (K) By Region

Table 91: Global Liquid Embolic Device Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Liquid Embolic Device market size?

The Liquid Embolic Device market size reached roughly USD 1.2 billion in 2023, reflecting cumulative sales of polymer‑based, glue‑type, and foam embolics across North America, Europe, and Asia‑Pacific. This baseline underpins all subsequent growth projections for the industry.

2. What is the forecasted growth rate and market size by 2032?

Analysts project the Liquid Embolic Device market to expand at a 5.8 % compound annual growth rate through 2032, reaching approximately USD 2.1 billion. The trajectory is driven by rising neuro‑interventional procedures and expanding indications in peripheral vascular therapy.

3. Which factors are the primary drivers of market expansion?

Key drivers include the growing adoption of minimally invasive endovascular therapies, an aging global population that increases cerebrovascular disease prevalence, favorable reimbursement policies in major health systems, and continuous innovation in polymer chemistry that improves occlusion control and safety.

4. What are the main challenges facing the Liquid Embolic Device market?

Challenges stem from stringent regulatory approval pathways, especially for novel bio‑adhesive formulations, high device acquisition costs that limit adoption in price‑sensitive regions, a steep learning curve for interventionalists, and competition from detachable coils and mechanical occlusion systems.

5. Which regions lead the Liquid Embolic Device market and why?

North America remains the dominant region, driven by robust healthcare infrastructure and early technology adoption, while Europe follows with strong reimbursement frameworks. Asia‑Pacific is the fastest‑growing market, propelled by expanding interventional radiology networks and rising middle‑class healthcare spending.

6. Who are the top companies competing in this market?

The competitive landscape is led by Medtronic, Stryker, Boston Scientific, Terumo, and MicroVention, each offering proprietary liquid embolic platforms. These firms differentiate through clinical evidence generation, strategic partnerships with neuro‑interventional societies, and aggressive pipeline investments.

7. What future opportunities could reshape the Liquid Embolic Device market?

Future outlook highlights opportunities in combo embolic‑drug systems, AI‑guided delivery optimization, and patient‑specific polymer formulations enabled by 3‑D printing. Expanding indications into tumor embolization and peripheral artery disease also promise to broaden the addressable market.

8. How is technology influencing product development in this sector?

Advanced technology drives product evolution through nanostructured polymers that enhance occlusion precision, bio‑resorbable matrices that reduce long‑term foreign‑body reactions, and integrated imaging markers that enable real‑time visualization during deployment. These innovations also support shorter procedural times and lower radiation exposure, aligning with hospital efficiency goals.

9. What is the regulatory landscape for Liquid Embolic Devices worldwide?

Regulatory oversight varies by region: the U.S. FDA classifies liquid embolics as Class III devices requiring Premarket Approval, while Europe follows the MDR with CE marking based on clinical conformity. Emerging markets are adopting harmonized guidelines, yet local clearance timelines remain a hurdle.

Contact for Full Report

Loading report content...

What Is the Global Liquid Embolic Device Market Worth in 2026?

Market Snapshot

Liquid Embolic Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Liquid Embolic Device Segmentation

Liquid Embolic Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Liquid Embolic Device market size?

2. What is the forecasted growth rate and market size by 2032?

3. Which factors are the primary drivers of market expansion?

4. What are the main challenges facing the Liquid Embolic Device market?

5. Which regions lead the Liquid Embolic Device market and why?

6. Who are the top companies competing in this market?

7. What future opportunities could reshape the Liquid Embolic Device market?

8. How is technology influencing product development in this sector?

9. What is the regulatory landscape for Liquid Embolic Devices worldwide?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Liquid Embolic Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Liquid Embolic Device Segmentation

Liquid Embolic Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Liquid Embolic Device market size?

2. What is the forecasted growth rate and market size by 2032?

3. Which factors are the primary drivers of market expansion?

4. What are the main challenges facing the Liquid Embolic Device market?

5. Which regions lead the Liquid Embolic Device market and why?

6. Who are the top companies competing in this market?

7. What future opportunities could reshape the Liquid Embolic Device market?

8. How is technology influencing product development in this sector?

9. What is the regulatory landscape for Liquid Embolic Devices worldwide?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation